Hedgehog develops new anticancer drugs targeting the Hedgehog gene, involved in embryonic development and cell growth.

Vision and Mission: To innovate in the field of oncology by creating effective and targeted therapies for cancer treatment.

Noteworthy Points:

• Established in November 2018.
• Pipeline includes fully humanized antibodies and low-molecular compound treatments.
• Holds patents and has confirmed venture company status.